Poorly controlled diabetes with hypoglycemia risk | Dr. Nayan Jyoti Kurmi - EXCEL - Experiential Cases for Empagliflozin & Linagliptin - Podcast

エピソード

A 57-Year-Old Man with Type 2 Diabetes, Hypertension, and Microalbuminuria | Dr. Rachna Hathi Mazumder
12 7月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
Type 2 Diabetes patient with Hypertension and Microalbuminuria is showing clinical features of early changes of renal impairment. Listen to expert to manage inadequately controlled diabetes patients with novel emerging therapies.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Diabetic with Established Cardio-Vascular Disease | Dr. Mainak Banerjee
6 6月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
エピソードを見逃しましたか？

フィードを更新するにはここをクリックしてください。
Newly Diagnosed T2D with High Baseline HbA1c Level | Dr. Susovan Halder
29 5月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Poorly controlled diabetes with hypoglycemia risk | Dr. Santosh kumra Routray
16 3月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A middle-aged person with type 2 diabetes visited the clinic with inadequate control of glycemic profile along with episodes of hypoglycemia in the recent past. Listen to the expert to achieve the optimum management of type 2 diabetes with improving tolerability profile.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Diabetic with established Cardio-vascular disease | Dr. Manabbrota Gogoi
13 3月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Newly diagnosed T2D with high baseline HbA1c level | Dr. Sajjad Akbar
1 3月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Newly diagnosed T2D with high baseline HbA1c level | Dr. Chandan Sarmah
28 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Poorly controlled diabetes with hypoglycemia risk | Dr. Nayan Jyoti Kurmi
23 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A middle-aged person with type 2 diabetes visited the clinic with inadequate control of glycemic profile along with episodes of hypoglycemia in the recent past. Listen to the expert to achieve the optimum management of type 2 diabetes with improving tolerability profile.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Diabetic with established Cardio-vascular disease | Dr. Buddhadev Dutta
23 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Diabetic Cardiac Disease at high risk of HF | Dr. Pankaj Patawari
20 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A diabetic overweight patient with multi-organ target damage at high risk of developing heart failure is not able to achieve optimum target A1c level, what are factors we need to consider while individualizing the therapy in such patients? Listen to the expert.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Poorly controlled diabetes woman with genital tract infection | Dr. Manoj V Gedam
20 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
Poorly controlled diabetes patient with multiple CV risk factors on multiple medication came to visit clinician with genitourinary tract infection. Listen to expert the importance of individualizing the anti-diabetes therapy to achieve optimum glycemic control for better patient outcome.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
A 57-Year-Old Man with Type 2 Diabetes, Hypertension, and Microalbuminuria | Dr. Vijay Shankar Mishra
20 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
Type 2 Diabetes patient with Hypertension and Microalbuminuria is showing clinical features of early changes of renal impairment. Listen to expert to manage inadequately controlled diabetes patients with novel emerging therapies.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Newly diagnosed T2D with high baseline HbA1c level | Dr. Kirnesh Pandey
20 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Early Initiation With Empagliflozin And Linagliptin Combination For Optimal Glycemic Control |Dr. Shahnawaz Ahangar
17 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
Listen To The Expert On Early Initiation With Empagliflozin And Linagliptin Combination For Optimal Glycemic Control. Tune Into This Episode.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. Vaibhav Rohatgi
16 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A middle-aged patient with short duration of T2DM and multiple CV risk factors presents with uncontrolled hyperglycemia. What are the primary factors you would like to consider providing the comprehensive care to this patient? Listen to the expert.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Diabetic with established Cardio-vascular disease | Dr. Ansuman Dalbehra
16 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A T2DM patient with prior history of acute vascular event is recently diagnosed with type 2 diabetes mellitus. Listen to the expert to discuss the important aspects to assess and manage such patients.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
A 57-Year-Old Man with Type 2 Diabetes, Hypertension, and Microalbuminuria | Dr. Nadim Akhter Khan
16 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
Type 2 Diabetes patient with Hypertension and Microalbuminuria is showing clinical features of early changes of renal impairment. Listen to expert to manage inadequately controlled diabetes patients with novel emerging therapies.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Poorly controlled diabetes woman with genital tract infection | Dr. Sarfaraj Majid
16 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
Poorly controlled diabetes patient with multiple CV risk factors on multiple medication came to visit clinician with genitourinary tract infection. Listen to expert the importance of individualizing the anti-diabetes therapy to achieve optimum glycemic control for better patient outcome.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Early Initiation With Empagliflozin And Linagliptin Combination For Optimal Glycemic Control | Dr. Deepak Rastogi
15 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
Listen To The Expert On Early Initiation With Empagliflozin And Linagliptin Combination For Optimal Glycemic Control. Tune Into This Episode.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Newly diagnosed T2D with high baseline HbA1c level | Dr. Mohammed Riyaz
14 2月 2023· EXCEL - Experiential Cases for Empagliflozin & Linagliptin
A patient with newly detected T2D, came in the clinic with high baseline HbA1c level. Listen to expert the importance of optimum glycemic control early in the disease course for better patient outcome.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
もっと表示する

エピソード

A 57-Year-Old Man with Type 2 Diabetes, Hypertension, and Microalbuminuria | Dr. Rachna Hathi Mazumder

Diabetic with Established Cardio-Vascular Disease | Dr. Mainak Banerjee

Newly Diagnosed T2D with High Baseline HbA1c Level | Dr. Susovan Halder

Poorly controlled diabetes with hypoglycemia risk | Dr. Santosh kumra Routray

Diabetic with established Cardio-vascular disease | Dr. Manabbrota Gogoi

Newly diagnosed T2D with high baseline HbA1c level | Dr. Sajjad Akbar

Newly diagnosed T2D with high baseline HbA1c level | Dr. Chandan Sarmah

Poorly controlled diabetes with hypoglycemia risk | Dr. Nayan Jyoti Kurmi

Diabetic with established Cardio-vascular disease | Dr. Buddhadev Dutta

Diabetic Cardiac Disease at high risk of HF | Dr. Pankaj Patawari

Poorly controlled diabetes woman with genital tract infection | Dr. Manoj V Gedam

A 57-Year-Old Man with Type 2 Diabetes, Hypertension, and Microalbuminuria | Dr. Vijay Shankar Mishra

Newly diagnosed T2D with high baseline HbA1c level | Dr. Kirnesh Pandey

Early Initiation With Empagliflozin And Linagliptin Combination For Optimal Glycemic Control |Dr. Shahnawaz Ahangar

HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. Vaibhav Rohatgi

Diabetic with established Cardio-vascular disease | Dr. Ansuman Dalbehra

A 57-Year-Old Man with Type 2 Diabetes, Hypertension, and Microalbuminuria | Dr. Nadim Akhter Khan

Poorly controlled diabetes woman with genital tract infection | Dr. Sarfaraj Majid

Early Initiation With Empagliflozin And Linagliptin Combination For Optimal Glycemic Control | Dr. Deepak Rastogi

Newly diagnosed T2D with high baseline HbA1c level | Dr. Mohammed Riyaz